Invex Therapeutics Ltd.ASX: IXC

German Approval for IIH EVOLVE Phase 3 Clinical Trial

Mar 20, 2023 at 1:31 AM UTC · Issued by Invex Therapeutics Ltd.

Invex Therapeutics Ltd has released a press release.

View Attachment